The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
Abstract
The phenomenon of enhanced glycolysis in tumours has been acknowledged for decades, but biochemical evidence to explain it is only just beginning to emerge. A significant hint as to the triggers and advantages of enhanced glycolysis in tumours was supplied by the recent discovery that succinate dehydrogenase (SDH) and fumarate hydratase (FH) are tumour suppressors and which associated, for the first time, mitochondrial enzymes and their dysfunction with tumorigenesis. Further steps forward showed that the substrates of SDH and FH, succinate and fumarate, respectively, can mediate a 'metabolic signalling' pathway. Succinate or fumarate, which accumulate in mitochondria owing to the inactivation of SDH or FH, leak out to the cytosol, where they inhibit a family of prolyl hydroxylase enzymes (PHDs). Depending on the PHD inhibited, two newly recognized pathways that support tumour maintenance may ensue: affected cells become resistant to certain apoptotic signals and/or activate a pseudohypoxic response that enhances glycolysis and is conveyed by hypoxia-inducible factor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In animal models, fumarate hydratase inactivation induces a precancerous phenotype associated with chronic HIF pathway activation, highlighting the intersection of mitochondrial metabolism, redox homeostasis, and HIF regulation [229,230].”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [230]
In the citing paper
“These metabolic perturbations, which are tightly linked to altered cellular redox balance, result in pseudohypoxic signaling and increased cancer susceptibility [229,230].”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [230]
In the citing paper
“Mitochondrial dysfunction could impair oxidative phosphorylation, the TCA cycle, fatty acid oxidation, the urea cycle, gluconeogenesis, and apoptotic pathways (King et al., 2006; Modica-Napolitano and Singh, 2004).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as King et al., 2006
In the citing paper
“Loss-of-function mutations in SDH and FH cause a build-up of succinate and fumarate, respectively87. Accordingly, increased levels of succinate and fumarate caused by mutations in these genes can compete with αKG and inhibit activity of HIF hydroxylases and thus induce normoxic HIF1α activity in vitro88,89.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [87]
In the citing paper
“Interestingly, inherited mutations in fumarate hydratase, another Krebs cycle enzyme, have also been linked to a separate and equally rare inherited cancer syndrome 96 .”
From The common biology of cancer and ageing (2007) · cites this paper as [96]
Citations
Cites
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 4×
“Although both molecules were shown to mediate HIF induction (Isaacs et al., 2005; Selak et al., 2005), it is possible that they inhibit different PHDs with different efficiency.”
BackgroundInfluentialSelf-citationOxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
The key role of anaplerosis and cataplerosis for citric acid cycle function
Owen, O. E., Kalhan, S. C., & Hanson, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200006200 · Cited by 1,172 · cited 1×
“Moreover, enhanced glucose breakdown provides building blocks for the synthesis of nucleotides (via the pentose phosphate pathway), and amino and fatty acids (from glycolytic and TCA cycle intermediates) (Figure 1) (Owen et al., 2002).”
BackgroundOncogenic alterations of metabolism
Dang, C. V., & Semenza, G. L. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01344-9 · Cited by 1,106
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
Mitochondria, oxygen free radicals, disease and ageing
Raha, S., & Robinson, B. H. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01674-1 · Cited by 1,066 · cited 1×
“These are reactive oxygen species (ROS), which can be generated by the ETC, especially in complex I and III (Raha and Robinson, 2000).”
BackgroundDysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K. (2004) · Nature Genetics · doi:10.1038/ng1494 · Cited by 980
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 674
Sevda, S., Garlapati, V. K., Naha, S., Sharma, M., Ray, S. G., Sreekrishnan, T. R., & Goswami, P. (2020) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2020.01.003 · Cited by 39
Mapping of Succinate Dehydrogenase Losses in 2258 Epithelial Neoplasms
Miettinen, M., Sarlomo‐Rikala, M., McCue, P. A., Czapiewski, P., Langfort, R., Waloszczyk, P., Ważny, K., Biernat, W., Lasota, J. P., & Wang, Z. (2013) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e31828bfdd3 · Cited by 38
Chen, X., Overcash, R., Green, T., Hoffman, D. R., Asch, A. S., & Ruiz-Echevarría, M. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193805 · Cited by 38
Normoxic accumulation of HIF1α is associated with glutaminolysis
Kappler, M., Pabst, U., Rot, S., Taubert, H. W., Wichmann, H., Schubert, J., Bache, M., Weinholdt, C., Immel, U., Große, I., et al. (2016) · Clinical Oral Investigations · doi:10.1007/s00784-016-1780-9 · Cited by 38
Hypoxia decreases ROS level in human fibroblasts
Sgarbi, G., Gorini, G., Costanzini, A., Barbato, S., Solaini, G., & Baracca, A. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.05.005 · Cited by 40
Masetti, M., Acquaviva, G., Visani, M., Tallini, G., Fornelli, A., Ragazzi, M., Vasuri, F., Grifoni, D., Giacomo, S. D., Fiorino, S., et al. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170464 · Cited by 38
Hua, Y., Qiu, Y., Zhao, A., Wang, X., Chen, T., Zhang, Z., Chi, Y., Li, Q., Sun, W., Li, G., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200147g · Cited by 38
Altered expression levels of IDH2 are involved in the development of colon cancer
LV, Q., Xing, S., LI, Z., Li, J., Gong, P., Xu, X., CHANG, L., Jin, X., Gao, F., Li, W., et al. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.676 · Cited by 38
Saha, P. P., Kumar, S. K. P., Srivastava, S., Sinha, D., Pareek, G., & D’Silva, P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.526665 · Cited by 37
Jiang, X., & Elliott, R. L. (2017) · Anticancer Research · doi:10.21873/anticanres.11567 · Cited by 37
Fabian, A., Stegner, S. H., Miarka, L., Zimmermann, J., Lenk, L., Rahn, S., Buttlar, J., Viol, F., Knaack, H., Esser, D., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.039 · Cited by 37
Mechanisms of tumor promotion by reactive oxygen species
Kobliakov, V. A. (2010) · Biochemistry (Moscow) · doi:10.1134/s0006297910060015 · Cited by 37
Chronic hypoxia leads to a glycolytic phenotype and suppressed HIF-2 signaling in PC12 cells
Zhdanov, A. V., Dmitriev, R. I., Golubeva, A. V., Gavrilova, S. A., & Papkovsky, D. B. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.016 · Cited by 35
Protective effects of Polygonatum sibiricum polysaccharide on acute heart failure in rats
Zhu, X., Wu, W., Chen, X., Yang, F., Jianxin, Z., & Hou, J. (2018) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020180100000001 · Cited by 36
Colmenero, F. (2020) · Materials Advances · doi:10.1039/d0ma00019a · Cited by 36
TCA cycle-derived oncometabolites in cancer and the immune microenvironment
Sarkar, S., Chang, C.-I., Jean, J., & Wu, M. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01186-y · Cited by 39
Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma
Vícha, A., Taïeb, D., & Pacák, K. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0398 · Cited by 35
Molecular pathogenesis of tumorigenesis caused by succinate dehydrogenase defect
Moosavi, B., Zhu, X., Yang, W., & Yang, G. (2019) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2019.151057 · Cited by 37
Relevance of the Warburg Effect in Tuberculosis for Host-Directed Therapy
Cumming, B. M., Pacl, H. T., & Steyn, A. J. C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.576596 · Cited by 31
Three autocrine feedback loops determine HIF1α expression in chronic hypoxia
Qutub, A. A., & Popel, A. S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.07.004 · Cited by 37
Urayama, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i6.1707 · Cited by 36
Hypothesis: solid tumours behave as systemic metabolic dictators
Lee, Y., Chang, W., & Ma, W. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12794 · Cited by 35
Yim, J., Cho, S. W., Kim, B., Park, S., Han, Y. H., & Seo, S. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082666 · Cited by 33
Kondrashova, M. N., Zakharchenko, M. V., & Khunderyakova, N. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.04.020 · Cited by 33
Altered Mitochondrial Signalling and Metabolism in Cancer
Chattopadhyay, E., & Roy, B. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00043 · Cited by 36
Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects
Samec, M., Líšková, A., Koklesová, L., Zhai, K., Varghese, E., Samuel, S. M., Šudomová, M., Lučanský, V., Kassayová, M., Péč, M. J., et al. (2021) · Cancers · doi:10.3390/cancers13123018 · Cited by 33
Robust metabolic adaptation underlying tumor progression
Vizán, P., Mazurek, S., & Cascante, M. (2008) · Metabolomics · doi:10.1007/s11306-007-0101-3 · Cited by 35
Metabolic Signature of Pregnant Women with Neural Tube Defects in Offspring
Zheng, X., Su, M., Pei, L., Zhang, T., Ma, X., Qiu, Y., Xia, H., Wang, F., Zheng, X., Gu, X. F., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200666d · Cited by 33
Quercetin induced ROS production triggers mitochondrial cell death of human embryonic stem cells
Kim, S.-Y., Jeong, H., Hong, S.-K., Lee, M., Cho, S.-J., & Cha, H. (2016) · Oncotarget · doi:10.18632/oncotarget.11070 · Cited by 33
Niu, N., Ye, J., Hu, Z., Zhang, J., & Wang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087076 · Cited by 34
Metabolic modulation of cancer: a new frontier with great translational potential
Kinnaird, A. S., & Michelakis, E. D. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1250-2 · Cited by 32
Restricting carbohydrates to fight head and neck cancer-is this realistic?
Klement, R. J. (2014) · PubMed Central · doi:10.7497/j.issn.2095-3941.2014.03.001 · Cited by 33
Wang, Z., Du, M., Yuan, Q., Guo, Y., Hutchinson, J. N., Su, L., Zheng, Y., Wang, J., Mucci, L. A., Lin, X., et al. (2020) · Neoplasia · doi:10.1016/j.neo.2020.01.001 · Cited by 32
Renal Lipid Metabolism Abnormalities in Obesity and Clear Cell Renal Cell Carcinoma
Bobulescu, I. A., Pop, L. M., Mani, C., Turner, K., Rivera, C., Khatoon, S., Kairamkonda, S., Hannan, R., & Palle, K. (2021) · Metabolites · doi:10.3390/metabo11090608 · Cited by 32
A “Weird” Mitochondrial Fatty Acid Oxidation as a Metabolic “Secret” of Cancer
Zhelev, Z., Aoki, I., Lazarova, D., Vlaykova, T. I., Higashi, T., & Bakalova, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2339584 · Cited by 34
Eletsky, A., Jeong, M.-Y., Kim, H. L., Lee, H., Xiao, R., Pagliarini, D. J., Prestegard, J. H., Winge, D. R., Montelione, G. T., & Szyperski, T. (2012) · Biochemistry · doi:10.1021/bi301171u · Cited by 32
Succinate as a signaling molecule in the mediation of liver diseases
Chen, H., Jin, C., Xie, L. H., & Wu, J. H. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166935 · Cited by 34
Survival of the fittest: metabolic adaptations in cancer
Berardi, M. J., & Fantin, V. R. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.001 · Cited by 30
A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer
Tessem, M., Bertilsson, H., Angelsen, A., Bathen, T. F., Drabløs, F., & Rye, M. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153727 · Cited by 31
Role of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors
Zhao, Y., Feng, F., Guo, Q., Wang, Y., & Zhao, R. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i34.5074 · Cited by 35
Jiang, W., Zhu, Z., & Thompson, H. J. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20425 · Cited by 32
Imaging mitochondrial redox potential and its possible link to tumor metastatic potential
Li, L. Z. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9469-5 · Cited by 32
Kuo, C., Cheng, C.-T., Hou, P., Lin, Y.-P., Ma, H., Chung, Y., Chi, K. K., Chen, Y., Li, W., Kung, H.-J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8570 · Cited by 32
Flores, R. E., Brown, A. K., Taus, L. J., Khoury, J., Glover, F., Kami, K., Sarangarajan, R., Walshe, T. E., Narain, N. R., Kiebish, M. A., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2018.03.012 · Cited by 31
Lotze, M. T., Maranchie, J. K., & Appleman, L. J. (2013) · The Cancer Journal · doi:10.1097/ppo.0b013e31829da0d6 · Cited by 31
Euceda, L. R., Haukaas, T. H., Giskeødegård, G. F., Vettukattil, R., Engel, J., Silwal‐Pandit, L., Lundgren, S., Borgen, E., Garred, Ø., Postma, G., et al. (2017) · Metabolomics · doi:10.1007/s11306-017-1168-0 · Cited by 29
Conza, G. D., Cafarello, S. T., Zheng, X., Zhang, Q. H., & Mazzone, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.081 · Cited by 29
Oncometabolites and the response to radiotherapy
Xiang, K., Jendrossek, V., & Matschke, J. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01638-9 · Cited by 30
Qiao, S., Lu, W., Glorieux, C., Li, J., Zeng, P., Meng, N., Zhang, H., Wen, S., & Huang, P. (2021) · Oncogene · doi:10.1038/s41388-021-01968-2 · Cited by 30
Shannar, A., Sarwar, M. S., & Kong, A. T. (2022) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2022.27.4.335 · Cited by 29
Novel insight into the Warburg effect: Sweet temptation
Zhang, H., Liu, S., Fu, S., Zhao, Q., Wang, Y., Yuan, Y., & Zhang, C. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104844 · Cited by 33
Klupczyńska, A., Plewa, S., Sytek, N., Sawicki, W., Dereziński, P., Matysiak, J., & Kokot, Z. J. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.06.059 · Cited by 28
UCP2 induces metabolic reprogramming to inhibit proliferation of cancer cells
Estèves, P., Pecqueur, C., & Alves‐Guerra, M. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.975024 · Cited by 28
Pino, E. C., Wang, H., McDonald, M. E., Qiang, L., & Farmer, S. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.350918 · Cited by 27
Kim, S., Park, Y., Yoo, Y., & Cho, H. (2015) · FEBS Journal · doi:10.1111/febs.13568 · Cited by 27
Derbré, S., Gil, S., Taverna, M., Boursier, C., Nicolas, V., Demey, E., Vinh, J., Susín, S. A., Hocquemiller, R., & Poupon, E. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.09.091 · Cited by 27
Reprogramming of tumor-associated macrophages by metabolites generated from tumor microenvironment
Kim, S. W., Kim, C. W., Moon, Y.-A., & Kim, H. S. (2024) · Animal Cells and Systems · doi:10.1080/19768354.2024.2336249 · Cited by 28
Metabolism and epigenetics: drivers of tumor cell plasticity and treatment outcomes
Gantner, B. N., Palma, F. R., Pandkar, M. R., Sakiyama, M. J., Arango, D., DeNicola, G. M., Gomes, A. P., & Bonini, M. G. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.08.005 · Cited by 29
Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease
Mohamed, F. A., Thangavelu, G., Rhee, S. Y., Sage, P. T., O’Connor, R. S., Rathmell, J. C., & Blazar, B. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.757836 · Cited by 26
Sammad, A., Hu, L., Luo, H., Abbas, Z., Umer, S., Zhao, S., Xu, Q., Khan, A. A., Wang, Y., Zhu, H., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042146 · Cited by 26
Johnson, C. H., Santidrián, A. F., LeBoeuf, S. E., Kurczy, M. E., Rattray, N. J. W., Rattray, Z., Warth, B., Ritland, M., Hoang, L. T., Loriot, C., et al. (2017) · Cancer & Metabolism · doi:10.1186/s40170-017-0171-2 · Cited by 25
The Emerging Role of Succinate Dehyrogenase Genes (SDHx) in Tumorigenesis
Nazar, E., Khatami, F., Saffar, H., & Tavangar, S. M. (2019) · International Journal of Hematology-Oncology and Stem Cell Research · doi:10.18502/ijhoscr.v13i2.692 · Cited by 26
Hards, K., Adolph, C., Harold, L. K., McNeil, M. B., Cheung, C., Jinich, A., Rhee, K. Y., & Cook, G. M. (2019) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2019.11.003 · Cited by 28
Porphyromonas somerae Invasion of Endometrial Cancer Cells
Crooks, T. A., Madison, J. D., Walsh, D. M., Herbert, W. G., Jeraldo, P., Chia, N., Cliby, W. A., Kaufmann, S. H., & Walther-Antonio, M. R. S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.674835 · Cited by 25
Metabolic memory underlying minimal residual disease in breast cancer
Shechter, K. R., Kafkia, E., Zirngibl, K., Gawrzak, S., Alladin, A., Machado, D., Lüchtenborg, C., Sévin, D. C., Brügger, B., Patil, K. R., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202010141 · Cited by 25
Barreto, P. L. M., Okura, V. K., Pena, I. A., Maia, R., Maia, I. G., & Arruda, P. (2015) · Journal of Experimental Botany · doi:10.1093/jxb/erv460 · Cited by 25
Zhang, L., Qiu, L., Xu, S., Cheng, X. F., Wu, J., Wang, Y., Gao, W., Bao, J., & Yu, H. (2023) · Toxicology in Vitro · doi:10.1016/j.tiv.2023.105669 · Cited by 24
Holotnakova, T., Ziegelhöffer, A., Ohradanova‐Repic, A., Hulı́ková, A., Novàkovâ, M., Kopáček, J., Pastorek, J., & Pastoreková, S. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0400-6 · Cited by 24
The impact of mitochondria on cancer treatment resistance
van der Merwe, M., van Niekerk, G., Fourie, C., du Plessis, M., & Engelbrecht, A. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00623-y · Cited by 24
Charchar, H. L. S., & Fragoso, M. C. B. V. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac041 · Cited by 27
Exploiting Metabolic Differences in Glioma Therapy
Galeffi, F., & Turner, D. A. (2012) · Current Drug Discovery Technologies · doi:10.2174/157016312803305906 · Cited by 23
MicroRNA-96-3p promotes metastasis of papillary thyroid cancer through targeting SDHB
Zhao, X., Li, Y., & Zhou, Y. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1003-y · Cited by 22
Novel Mitochondria-targeted Drugs for Cancer Therapy
Fialová, J. L., Raudenská, M., Jakubek, M., Kejík, Z., Pavel Martasek, E., Babula, P., Matkowski, A., Filipenský, P., & Masařík, M. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666201118153242 · Cited by 22
Metabolic sensors and their interplay with cell signalling and transcription
Krejčı́, A. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110767 · Cited by 23
Zhang, R., Ji, J., Blaženović, I., Pi, F., Wang, T., Zhang, Y., & Sun, X. (2018) · Toxins · doi:10.3390/toxins10110441 · Cited by 23
Joyal, J., Omri, S., Sitaras, N., Rivera, J., Sapieha, P. S., & Chemtob, S. (2012) · Acta Paediatrica · doi:10.1111/j.1651-2227.2012.02692.x · Cited by 21
Exploring the association of succinate dehydrogenase complex mutations with lymphoid malignancies
Renella, R., Carnevale, J. C., Schneider, K. A., Hornick, J. L., Rana, H. Q., & Janeway, K. A. (2014) · Familial Cancer · doi:10.1007/s10689-014-9725-4 · Cited by 21
Mitochondrial Signaling in Hypoxia
Lukyanova, L. D. (2013) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2013.32a004 · Cited by 22
Sugiyama, M., TAKENAGA, F., Kitani, Y., Yamamoto, G., Okamoto, H., Masaoka, T., Araki, K., Nagoya, H., & Mori, T. (2012) · Biology Open · doi:10.1242/bio.20121263 · Cited by 21
Cellular Respiration and Carcinogenesis
Sarangarajan, R., & Apte, S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-435-3 · Cited by 20
Yan, X., Zhuo, Y., Bian, X., Li, J., Zhang, Y., Ma, L., Lu, G., Guo, M., Wu, J., & Li, N. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00350 · Cited by 21
The hypoxic microenvironment: A determinant of cancer stem cell evolution
Carnero, A., & LLeonart, M. E. (2015) · Inside the Cell · doi:10.1002/icl3.1039 · Cited by 23
Fumarate hydratase as a therapeutic target in renal cancer
Kancherla, P., Daneshvar, M., Sager, R., Mollapour, M., & Bratslavsky, G. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1804862 · Cited by 20
Changes in Metabolism as a Diagnostic Tool for Lung Cancer: Systematic Review
Mariën, H., Derveaux, E., Vanhove, K., Adriaensens, P., Thomeer, M., & Mesotten, L. (2022) · Metabolites · doi:10.3390/metabo12060545 · Cited by 19
Hereditary succinate dehydrogenase-deficient renal cell carcinoma
Rogala, J., & Zhou, M. (2023) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2023.11.001 · Cited by 20
Patiño, C. E. H., Jaime-Muñoz, G., & Reséndis-Antonio, O. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2012.00481 · Cited by 20
Nikam, A. P., Patankar, J. V., Lackner, C., Schöck, E., Kratky, D., Zatloukal, K., & Abuja, P. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066094 · Cited by 20
Boettcher, M., Lawson, A. R. J., Ladenburger, V., Fredebohm, J., Wolf, J. M., Hoheisel, J. D., Frezza, C., & Shlomi, T. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-158 · Cited by 22
Kitazawa, M., Hatta, T., Sasaki, Y., Fukui, K., Ogawa, K., Fukuda, E., Goshima, N., Okita, N. T., Yamada, Y., Nakagama, H., et al. (2019) · Cancer Science · doi:10.1111/cas.14275 · Cited by 20
Weinkauf, M., Zimmermann, Y., Hartmann, E., Rosenwald, A., Rieken, M., Pastore, A., Hutter, G., Hiddemann, W., & Dreyling, M. H. (2009) · Electrophoresis · doi:10.1002/elps.200800508 · Cited by 20
Dilger, M., Armant, O., Ramme, L., Mülhopt, S., Sapcariu, S. C., Schlager, C., Dilger, E., Reda, A., Orasche, J., Schnelle‐Kreis, J., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108169 · Cited by 20
Specific cyprinid HIF isoforms contribute to cellular mitochondrial regulation
Chen, J., Guan, L., Zou, M., He, S., Li, D., & Chi, W. (2020) · Scientific Reports · doi:10.1038/s41598-020-74210-w · Cited by 19
Targeting lipid metabolism in cancer: neuroblastoma
Agostini, M., Melino, G., Habeb, B. F., Calandria, J. M., & Bazan, N. G. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10040-8 · Cited by 20
Romick‐Rosendale, L. E., Lagomarcino, A. J., Patel, N. B., Morrow, A. L., & Kennedy, M. A. (2013) · Metabolomics · doi:10.1007/s11306-013-0546-5 · Cited by 18
Early alterations in protein and gene expression in rat kidney following bromate exposure
Ahlborn, G. J., Delker, D. A., Roop, B. C., Geter, D. R., Allen, J. W., DeAngelo, A. B., & Winnik, W. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.02.003 · Cited by 19
O’Farrell, N. J., Feighery, R., Picardo, S. L., Lynam‐Lennon, N., Biniecka, M., McGarrigle, S. A., Phelan, J. J., MacCarthy, F., O’Toole, D., Fox, E., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2544-2 · Cited by 19
Rapamycin as a potential treatment for succinate dehydrogenase deficiency
Fan, F., Sam, R., Ryan, E., Alvarado, K., & Villa-Cuesta, E. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e01217 · Cited by 17
Zhang, S., Cao, L., Li, Z., & Qu, D. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.045 · Cited by 20
Dysfunctional MDR-1 disrupts mitochondrial homeostasis in the oocyte and ovary
Clark, H., Knapik, L. O., Zhang, Z., Wu, X., Naik, M. T., Oulhen, N., Wessel, G. M., & Brayboy, L. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-46025-x · Cited by 19
Jaidee, R., Kongpetch, S., Senggunprai, L., Prawan, A., Kukongviriyapan, U., & Kukongviriyapan, V. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01885-3 · Cited by 19
Metadata
- Authors
- King, A., Selak, M. A., & Gottlieb, E.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Corresponding author
- Gottlieb, E
- Venue
- Oncogene
- Published
- 2006-08-07
- Volume
- 25
- Issue
- 34
- Pages
- 4675-4682
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2005828644
- Semantic Scholar
- 960f2f114b8beb17db8bd6d91cd79f788b80738a
- Cited by
- 672
- References
- 61
- Citations by year
- 2026: 21 · 2025: 22 · 2024: 19 · 2023: 25 · 2022: 42 · 2021: 39 · 2020: 38 · 2019: 37 · 2018: 37 · 2017: 42 · 2016: 39 · 2015: 37 · 2014: 42 · 2013: 37 · 2012: 52
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- succinate dehydrogenase, fumarate hydratase, mitochondrial dysfunction, tumour suppressor, succinic acid, fumarate, metabolic signalling, prolyl hydroxylase inhibition, pseudohypoxia, hypoxia-inducible factor, apoptosis resistance, carcinogenesis
- MeSH terms
- Fumarate Hydratase, Humans, Mitochondria, Neoplasms, Succinate Dehydrogenase, Genes, Tumor Suppressor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
